KNSA Stock Summary and Trading Ideas (Kiniksa Pharmaceuticals Ltd. - Class A | NASDAQ:KNSA)

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404.

Kiniksa Pharmaceuticals Ltd. - Class A trades on the NASDAQ stock market under the symbol KNSA.

As of April 19, 2024, KNSA stock price climbed to $16.91 with 351,256 million shares trading.

KNSA has a beta of 0.95, meaning it tends to be less sensitive to market movements. KNSA has a correlation of 0.06 to the broad based SPY ETF.

KNSA has a market cap of $1.18 billion. This is considered a Small Cap stock.

Last quarter Kiniksa Pharmaceuticals Ltd. - Class A reported $83 million in Revenue and $.35 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.49.

In the last 3 years, KNSA stock traded as high as $22.09 and as low as $7.36.

The top ETF exchange traded funds that KNSA belongs to (by Net Assets): XBI, VTI, VB, IWM, VBR.

KNSA has outperformed the market in the last year with a return of +43.8%, while the SPY ETF gained +21.2%. However, in the most recent history, KNSA shares have underperformed the stock market with its stock returning -9.9% in the last 3 month period and -6.4% for the last 2 week period, while SPY has returned +4.3% and -3.5%, respectively.

KNSA support price is $16.52 and resistance is $17.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KNSA stock will trade within this expected range on the day.